	Ebit		日
Acadia Pharmaceuticals	USD 37.84M	42.45M	2026-06
Adma Biologics	USD 59.23M	3.52M	2026-03
ALKERMES	USD -65.93M	17.65M	2026-06
Alterity Therapeutics Limited	AUD -8.07M	302.4K	2025-12
AstraZeneca	USD 3.16B	3.95B	2026-06
BioCryst Pharmaceuticals	USD 98.46M	161.92M	2026-06
Bristol-Myers Squibb	USD 299M	3.26B	2026-06
Cipla	INR 8.88B	2.74B	2026-06
Clal Biotechnology	ILS -5.44M	3.76M	2022-12
Compugen	USD -9.02M	65.06M	2026-03
CSL	USD 2.64B	116M	2025-12
Eli Lilly	USD 12.46B	2.68B	2026-06
GlaxoSmithKline	GBP 2.6B	312M	2026-06
Grifols	EUR 320.55M	91.01M	2025-12
Halozyme Therapeutics	USD -63.72M	1.95M	2026-06
Ionis Pharmaceuticals	USD -102.29M	15.71M	2026-06
J&J	USD 6.47B	1B	2026-09
Merck	USD 840M	2.72B	2026-06
Minerva Neurosciences	USD -4.37M	1.71M	2024-09
Neurocrine Biosciences	USD 219.9M	5.3M	2026-06
Novartis	USD 4.73B	549M	2026-06
Novavax	USD 20.94M	100.32M	2025-12
Pfizer	USD -180M	5.16B	2026-06
Roche Holding	CHF 11.46B	1.91B	2026-06
Sanofi	EUR 1.12B	811M	2026-06
Takeda	JPY 201.42B	215.04B	2026-06
Vanda Pharmaceuticals	USD -10.28M	721K	2024-12